18th esgo: clinical trials, engot and use of bevacizumab against angiogenesis
Published 10 years ago • 209 plays • Length 6:40Download video MP4
Download video MP3
Similar videos
-
4:26
18th esgo: results from the trinova 1 trial
-
4:43
understanding gog-0218 & icon7 trials
-
11:46
esmo 2010: the icon7 trial
-
4:52
overview of esgo 2011
-
22:08
s. de falco - inhibition of pathological angiogenesis: targeting vessels and inflammation
-
3:49
ecco 15- esmo 34, berlin 2009: guidelines for safer handling of cytotoxics
-
1:16
αβ t-cell depleted allo-hsct for hematological malignancies
-
23:45
oligometastatic disease: esophageal neoplasm case 3
-
1:28
future approaches in esophageal cancer
-
6:02
esdo learning bytes anti egfr induced skin toxicity by violaine randrian
-
17:53
agd 2020 - session 1: single cell transcriptomics and covid-19 disease trajectories by j. bernardes
-
0:40
altogen labs sw480 xenograft service colon cancer
-
3:01
esophageal cancer by staci e. beamer, md | preview
-
2:13
meet ramez eskander, md: gynecologic oncologist
-
0:40
altogen labs hct116 xenograft service colon cancer
-
1:22
react: elispot assay predicts cmv reactivation in allo-hsct patients
-
3:01
bylieve additional cohort: update on the trial of alpelisib in advanced breast cancer from esmo
-
0:43
aleksandra strojna 🇵🇱 invites you to enygo session 1 #enygoprague2021